Abstract
Background: Vitamin D has a role in the pathogenesis of many medical disorders, especially those of the central nervous system. It is essential in maintaining the bone health of children. However, patients with epilepsy are at high risk of developing vitamin D deficiency due to antiseizure medications (ASMs). Therefore, we aimed to assess the prevalence of vitamin D deficiency and related risk factors in children with epilepsy. Methods: This is the baseline report of a pragmatic, randomized, controlled, open-label trial that assessed the impact of vitamin D supplementation in preventing vitamin D deficiency (NCT03536845). We included children with epilepsy aged 2–16 years who were treated with ASMs from December 2017 to March 2021. Children with preexisting vitamin D metabolism problems, vitamin-D-dependent rickets, malabsorption syndromes, renal disease, and hepatic disease were excluded. The baseline demographic data, anthropometric measurements, seizure types, epilepsy syndromes, ASMs, and seizure control measures were recorded. Blood tests for vitamin D (25-hydroxyvitamin D [25(OH)D), serum calcium, serum phosphorus, and parathyroid hormone levels were performed. Based on vitamin D concentration, patients were categorized as deficient (<50 nmol/L), insufficient (74.9–50 nmol/L), or normal (>75 nmol/L). Results: Of 159 recruited children, 108 (67.92%) had generalized seizures, 44 (27.67%) had focal seizures, and 7 (4.4%) had unknown onset seizures. The number of children receiving monotherapy was 128 (79.0%) and 31 (19.1%) children were receiving polytherapy. The mean vitamin D concentration was 60.24 ± 32.36 nmol/L; 72 patients (45.28%) had vitamin D deficiency and 45 (28.3%) had vitamin D insufficiency. No significant difference in vitamin D concentration was observed between children receiving monotherapy and those receiving polytherapy. The main risk factors of vitamin D deficiency were obesity and receiving enzyme-inducer ASMs. Conclusions: The prevalence of vitamin D deficiency was high among children with epilepsy. Obese children with epilepsy and those on enzyme-inducer ASMs were at increased risk for vitamin D deficiency. Further studies are needed to establish strategies to prevent vitamin D deficiency.
Funder
Dallah Healthcare, Kingdom of Saudi Arabia
Subject
Pediatrics, Perinatology and Child Health
Reference32 articles.
1. Muthayya, S., Rah, J.H., Sugimoto, J.D., Roos, F.F., Kraemer, K., and Black, R.E. (2013). The Global Hidden Hunger Indices and Maps: An Advocacy Tool for Action. PLoS ONE, 8.
2. Vitamin D and systemic lupus erythematous: A review of immunological and clinical aspects;Clin. Exp. Rheumatol.,2018
3. Optimal Vitamin D Supplementation Levels for Cardiovascular Disease Protection;Dis. Markers,2015
4. Sommer, I., Griebler, U., Kien, C., Auer, S., Klerings, I., Hammer, R., Holzer, P., and Gartlehner, G. (2017). Vitamin D deficiency as a risk factor for dementia: A systematic review and meta-analysis. BMC Geriatr., 17.
5. Serum Vitamin D and the Risk of Parkinson Disease;Arch. Neurol.,2010
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献